A study to determine patient specific and general beliefs towards medication and their treatment compliance to selected systemic therapies in chronic inflammatory diseases (ALIGN)

Multi-country, cross sectional study to determine patient specific and General beliefs towards medication and their treatment compliance to selected systemic therapies in chronic inflammatory diseases (IMID)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12612000977875

Acronym

ALIGN

Enrollment

330

Registered

2012-09-11

Start date

2012-09-11

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of the ALIGN study is to better understand patient’s attitudes, beliefs and risks concerns towards their systemic medication.The ALIGN study deals with the collection of information only and is not designed for drug testing. You will also be asked to complete four types of questionnaires and one visual analog scale which will take approximately 30 to 45 minutes. You will have the opportunity to seal your answered questionnaires in an envelope so that they are not disclosed to your treating doctor.

Interventions

Non-interventional Questionnaire study. Looking at understanding better patient's attitudes, beliefs and risk concerns towards their systemic medication. Duration of the study is a single visit to complete 4 questionnaires. The questionnaires will take 30-45 minutes to complete.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Female/male 18 years or over Patients with Immune Mediated Inflammatory Disorders as diagnosed by a rheumatologist, gastroenterologist or dermatologist. On current treatment with systemic either conventional and/or biologic immuno-modulating and/or disease-modifying drugs.

Exclusion criteria

Not applicable

Outcome results